Adriana de Oliveira Veríssimo

Adriana de Oliveira Veríssimo


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2023 in Viruses
Verified
Journal Article
Open access
PDF file
FRFabíola Brasil Barbosa Rodrigues
Fabíola Brasil Barbosa Rodrigues
RSRosilene da Silva
Rosilene da Silva
ESErika Ferreira dos Santos
Erika Ferreira dos Santos
MBMioni Thieli Figueiredo Magalhães de Brito
Mioni Thieli Figueiredo Magalhães de Brito
ASAndréa Luciana Soares da Silva
Andréa Luciana Soares da Silva
ESEduardo José Melo dos Santos
Eduardo José Melo dos Santos
Interleukin-6 has been recognized as a major role player in COVID-19 severity, being an important regulator of the cytokine storm. Hence, the evaluation of the influence of polymorphisms in key genes of the IL-6 pathway, namely IL6, IL6R, and IL6ST, may provide valuable prognostic/predictive markers for COVID-19. The present cross-sectional study genotyped three SNPs (rs1800795, rs2228145, and rs7730934) at IL6. IL6R and IL6ST genes, respectively, in 227 COVID-19 patients (132 hospitalized and 95 non-hospitalized). Genotype frequencies were compared between these groups. As a control group, published data on gene and genotype frequencies were gathered from published studies before the pandemic started. Our major results point to an association of the IL6 C allele with COVID-19 severity. Moreover, IL-6 plasmatic levels were higher among IL6 CC genotype carriers. Additionally, the frequency of symptoms was higher at IL6 CC and IL6R CC genotypes. In conclusion, the data suggest an important role of IL6 C allele and IL6R CC genotype on COVID-19 severity, in agreement with indirect evidence from the literature about the association of these genotypes with mortality rates, pneumonia, and heightening of protein plasmatic levels pro-inflammatory driven effects.

31 March 2023 in Viruses
Verified
Journal Article
Open access
PDF file
SSSinei Ramos Soares
Sinei Ramos Soares
KTKaroliny Torres
Karoliny Torres
SLSandra Lima
Sandra Lima
KSKevin Matheus Lima de Sarges
Kevin Matheus Lima de Sarges
ESErika Ferreira dos Santos
Erika Ferreira dos Santos
ASAndréa Nazaré Monteiro Rangel da Silva
Andréa Nazaré Monteiro Rangel da Silva
The first case of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in Brazil was diagnosed on February 26, 2020. Due to the important epidemiological impact of COVID-19, the present study aimed to analyze the specificity of IgG antibody responses to the S1, S2 and N proteins of SARS-CoV-2 in different COVID-19 clinical profiles. This study enrolled 136 individuals who were diagnosed with or without COVID-19 based on clinical findings and laboratory results and classified as asymptomatic or as having mild, moderate or severe disease. Data collection was performed through a semistructured questionnaire to obtain demographic information and main clinical manifestations. IgG antibody responses to the S1 and S2 subunits of the spike (S) protein and the nucleocapsid (N) protein were evaluated using an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s instructions. The results showed that among the participants, 87.5% (119/136) exhibited IgG responses to the S1 subunit and 88.25% (120/136) to N. Conversely, only 14.44% of the subjects (21/136) displayed S2 subunit responses. When analyzing the IgG antibody response while considering the different proteins of the virus, patients with severe disease had significantly higher antibody responses to N and S1 than asymptomatic individuals (p ≤ 0.0001), whereas most of the participants had low antibody titers against the S2 subunit. In addition, individuals with long COVID-19 showed a greater IgG response profile than those with symptomatology of a short duration. Based on the results of this study, it is concluded that levels of IgG antibodies may be related to the clinical evolution of COVID-19, with high levels of IgG antibodies against S1 and N in severe cases and in individuals with long COVID-19.

22 April 2024 in Viruses
Verified
Journal Article
Open access
PDF file
KSKevin Matheus Lima de Sarges
Kevin Matheus Lima de Sarges
Flavia Povoa da CostaFlavia Povoa da Costa
Flavia Povoa da Costa
ESErika Ferreira dos Santos
Erika Ferreira dos Santos
MCMarcos Henrique Damasceno Cantanhede
Marcos Henrique Damasceno Cantanhede
RSRosilene da Silva
Rosilene da Silva
ESEduardo José Melo dos Santos
Eduardo José Melo dos Santos
Tumor necrosis factor (TNF) and interferon-gamma (IFNγ) are important inflammatory mediators in the development of cytokine storm syndrome (CSS). Single nucleotide polymorphisms (SNPs) regulate the expression of these cytokines, making host genetics a key factor in the prognosis of COVID-19. In this study, we investigated the associations of the TNF -308G/A and IFNG +874T/A polymorphisms with COVID-19. We analyzed the frequencies of the two polymorphisms in the control groups (CG: TNF -308G/A, n = 497; IFNG +874T/A, n = 397), a group of patients with COVID-19 (CoV, n = 222) and among the subgroups of patients with nonsevere (n = 150) and severe (n = 72) COVID-19. We found no significant difference between the genotypic and allelic frequencies of TNF -308G/A in the groups analyzed; however, both the frequencies of the high expression genotype (TT) (CoV: 13.51% vs. CG: 6.30%; p = 0.003) and the *T allele (CoV: 33.56% vs. CG: 24. 81%; p = 0.001) of the IFNG +874T/A polymorphism were higher in the COVID-19 group than in the control group, with no differences between the subgroups of patients with nonsevere and severe COVID-19. The *T allele of IFNG +874T/A (rs2430561) is associated with susceptibility to symptomatic COVID-19. These SNPs provided valuables clues about the potential mechanism involved in the susceptibility to developing symptomatic COVID-19.

1 October 2020 in Revista Pan-Amazônica de Saúde
Verified
Journal Article
Open access
PDF file
WSWeydder Tavares da Silva
Weydder Tavares da Silva
MTMilene Gouvêa Tyll
Milene Gouvêa Tyll
AMAna Cristina Cardoso de Sousa Miranda
Ana Cristina Cardoso de Sousa Miranda
GMGiovanna Pontes Moura
Giovanna Pontes Moura
AVAdriana de Oliveira Veríssimo
Adriana de Oliveira Veríssimo
Palavras-chave: Insuficiência Cardíaca; Prognóstico; Perfil de Saúde; Cardiopatias

Verified
Journal Article
Open access
PDF file
WBWandrey Roberto dos Santos Brito
Wandrey Roberto dos Santos Brito
WBWilliam Botelho de Brito
William Botelho de Brito
FFFabiane dos Santos Ferreira
Fabiane dos Santos Ferreira
ESEmmanuelle Giuliana Mendes Santana
Emmanuelle Giuliana Mendes Santana
JLJeferson da Costa Lopes
Jeferson da Costa Lopes
MQMARIA ALICE QUEIROZ
MARIA ALICE QUEIROZ
The apoptotic molecule Fas and its ligand FasL are involved in the process of T-lymphocyte death, which may lead to lymphopenia, a characteristic of severe coronavirus disease 2019 (COVID-19). In this study, we investigated the influence of polymorphisms in the FAS and FASL genes, FAS and FASL gene expression, and plasma cytokine levels on COVID-19 severity and long COVID occurrence. A total of 116 individuals with severe COVID-19 and 254 with the non-severe form of the disease were evaluated. In the post-COVID-19 period, samples from 196 individuals with long COVID and 67 from people who did not have long COVID were included. Genotyping and quantification of gene expression were performed via real-time PCR, and cytokine measurement was performed via flow cytometry. The AA genotype for FAS rs1800682 (A/G) and the TT genotype for FASL rs763110 (C/T) were associated with increased FAS and FASL gene expression, respectively (p < 0.005). Higher plasma IFN-γ levels were associated with higher FAS and FASL gene expression (p < 0.05). Among individuals with non-severe COVID-19, carriers of the AA genotype for FAS rs1800682 (A/G) had higher levels of FAS expression, more symptoms, and higher IFN-γ levels (p < 0.05). No association of the evaluated markers with long COVID were observed. The AA genotype of FAS rs1800682 (A/G) and the TT genotype of FASL rs763110 (C/T) influence the levels of FAS and FASL gene expression. Higher gene expression of FAS and FASL may lead to greater inflammation in COVID-19 patients, with higher levels of IFN-γ and T lymphocyte death.

14 April 2020 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
AVAdriana de Oliveira Veríssimo
Adriana de Oliveira Veríssimo
JHJuniel Pereira Honorato
Juniel Pereira Honorato
SCSilvio Douglas Medeiros Costa
Silvio Douglas Medeiros Costa
JGJoão Victor Moura Garcia
João Victor Moura Garcia
ISIsis Jaspe Reis da Silva
Isis Jaspe Reis da Silva
MTMilene Gouvêa Tyll
Milene Gouvêa Tyll
Heart failure is characterized as the lack of blood pumping capacity performed by the heart, which is considered a public health problem worldwide. Due to HF, the individual can develop clinical aspects that impact cognitive function and, consequently, self-care. Therefore, this study aimed to investigate cognitive changes and self-care in patients affected by HF and compare it with the cognitive and self-care changes of healthy participants. This is a quantitative, epidemiological, cross-sectional case-control study carried out at an institution in the city of Belém, Pará, Brazil. The following tests were used for data collection: Montreal Cognitive Assessment, Digit Symbol Substitution Test, European Heart Failure Self-care Behavior Scale (EHFScBS). Data were tabulated in Microsoft Excel 2010 and statistically treated by Epi Info version 3.5.2 with a 5% significance level and considering a 95% confidence interval in all analyzes. It was observed that patients with HF have slightly better self-care compared to patients without HF with scores obtained by EHFScBS equal to 29.7 ± 6.9 and 31.8 ± 8.2, respectively. Additionally, patients with HF showed impairments in the three cognitive domains, and women with HF demonstrated greater cognitive impairment compared to the other participants. The present study provides data to help build new approaches to interventions by the multidisciplinary team to promote better self-care and avoid cognitive impairments in patients with HF.